Mahboobeh Mahdavinia

Prof. Dr. Mahboobeh Mahdavinia

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2015 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
WSWhitney W. Stevens
Whitney W. Stevens
COChristopher J. Ocampo
Christopher J. Ocampo
SBSergejs Berdnikovs
Sergejs Berdnikovs
MSMasafumi Sakashita
Masafumi Sakashita
MMMahboobeh Mahdavinia
Mahboobeh Mahdavinia
RSRobert P. Schleimer
Robert P. Schleimer
Rationale: The mechanisms that underlie the pathogenesis of chronic rhinosinusitis without nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and aspirin-exacerbated respiratory disease (AERD) are not clear. Objectives: To first evaluate the inflammatory profiles of CRSsNP and CRSwNP tissues and then to investigate whether clinical differences observed between CRSwNP and AERD are in part secondary to differences in inflammatory mediator expression within nasal polyp (NP) tissues. Methods: Expression levels of numerous inflammatory mediators were determined by quantitative real-time polymerase chain reaction, ELISA, and multiplex immunoassay. Measurements and Main Results: CRSwNP NP had increased levels of type 2 mediators, including IL-5 (P < 0.001), IL-13 (P < 0.001), eotaxin-2 (P < 0.001), and monocyte chemoattractant protein (MCP)-4 (P < 0.01), compared with sinonasal tissue from subjects with CRSsNP and control subjects. Expression of IFN-γ messenger RNA or protein was low and not different among the chronic rhinosinusitis subtypes examined. Compared with CRSwNP, AERD NP had elevated protein levels of eosinophil cationic protein (ECP) (P < 0.001), granulocyte–macrophage colony–stimulating factor (GM-CSF) (P < 0.01), and MCP-1 (P = 0.01), as well as decreased gene expression of tissue plasminogen activator (tPA) (P = 0.02). Despite the higher eosinophilia in AERD, there was no associated increase in type 2 mediator protein levels observed. Conclusions: CRSwNP was characterized by a predominant type 2 inflammatory environment, whereas CRSsNP did not reflect a classic type 1 milieu, as has been suggested previously. AERD can be distinguished from CRSwNP by elevated ECP levels, but this enhanced eosinophilia is not associated with elevations in traditional type 2 inflammatory mediators associated with eosinophil proliferation and recruitment. However, other factors, including GM-CSF, MCP-1, and tPA, may be important contributors to AERD pathogenesis.

1 July 2017 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
WSWhitney W. Stevens
Whitney W. Stevens
APAnju T. Peters
Anju T. Peters
AHAnnemarie G. Hirsch
Annemarie G. Hirsch
CNCara Nordberg
Cara Nordberg
BSBrian S. Schwartz
Brian S. Schwartz
RSRobert P. Schleimer
Robert P. Schleimer

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
FBFaraz Bishehsari
Faraz Bishehsari
MMMahboobeh Mahdavinia
Mahboobeh Mahdavinia
Michele VaccaMichele Vacca
Michele Vacca
RMReza Malekzadeh
Reza Malekzadeh
Renato Mariani-CostantiniRenato Mariani-Costantini
Renato Mariani-Costantini
Colorectal cancer (CRC) is one of the leading causes of cancer and cancer-related mortality worldwide. The disease has been traditionally a major health problem in industrial countries, however the CRC rates are increasing in the developing countries that are undergoing economic growth. Several environmental risk factors, mainly changes in diet and life style, have been suggested to underlie the rise of CRC in these populations. Diet and lifestyle impinge on nuclear receptors, on the intestinal microbiota and on crucial molecular pathways that are implicated in intestinal carcinogenesis. In this respect, the epidemiological transition in several regions of the world offers a unique opportunity to better understand CRC carcinogenesis by studying the disease phenotypes and their environmental and molecular associations in different populations. The data from these studies may have important implications for the global prevention and treatment of CRC.

28 October 2015 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
MMMahboobeh Mahdavinia
Mahboobeh Mahdavinia
AKA. Keshavarzian
A. Keshavarzian
MTM. C. Tobin
M. C. Tobin
ALA. L. Landay
A. L. Landay
RSR. P. Schleimer
R. P. Schleimer

1 April 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KHKathryn E. Hulse
Kathryn E. Hulse
JNJames E. Norton
James E. Norton
LSLydia Suh
Lydia Suh
QZQiu Zhong
Qiu Zhong
MMMahboobeh Mahdavinia
Mahboobeh Mahdavinia
RSRobert P. Schleimer
Robert P. Schleimer

1 March 2017 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
MMMahboobeh Mahdavinia
Mahboobeh Mahdavinia
SFSusan R. Fox
Susan R. Fox
BSBridget M. Smith
Bridget M. Smith
CJChristine James
Christine James
EPErica L. Palmisano
Erica L. Palmisano
RGRuchi S. Gupta
Ruchi S. Gupta